// App-Quantinova.ai

5095 : The International Prognostic Index Is a Better Predictor of Thrombotic Complications Than the Khorana Score for Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: Results of a Single Center Prospective Cohort Study

Researchers

Presenter

  • Ji Yoon Lee

Principal Investigators

  • Seok Jin Kim

  • Won Seog Kim

Medical Centers

  • Samsung Medical Center, Seoul, Korea

  • Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Locations

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Deep vein thrombosis

  • Venous thrombosis

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

  • Stroke

Biomarkers

  • Lactate dehydrogenase

  • Body mass index

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Vincristine

  • Doxorubicin

  • Prednisone

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT00822731

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved